| Gene symbol | E6 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_001526.4 (7125..7601) | dbXrefs | |
| Description | protein E6*;transforming protein E6 | ||||
| GTO ID | GTC3019 |
| Trial ID | NCT05357027 |
| Disease | Exocervical Carcinoma |
| Altered gene | E6 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | HPV-16 E6 TCR-T cells |
| HLA | HLA-A*02 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Phase I/II Clinical Trail of TC-E202 Targeting HPV16 E6 for Relapsed/Refractory to Standard Treatment or Metastatic Cervical Carcinoma |
| Year | 2022 |
| Country | China |
| Company sponsor | TCRCure Biopharma Ltd. |
| Other ID(s) | TC-E202-CC-PI |
| Cohort 1 | |||||||||
|
|||||||||